Neith Corporation (6236.TWO)
TWD 29.65
(0.0%)
TWD 29.65
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 714 Thousand TWD | -88.57% |
| 2022 | 6.24 Million TWD | 0.0% |
| 2021 | - TWD | -100.0% |
| 2020 | 1.18 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - TWD | 0.0% |
| 2024 Q2 | - TWD | 0.0% |
| 2023 Q3 | 1.42 Million TWD | -65.33% |
| 2023 FY | 714 Thousand TWD | -88.57% |
| 2023 Q1 | 5.19 Million TWD | 0.0% |
| 2023 Q2 | 4.11 Million TWD | -20.64% |
| 2023 Q4 | 714 Thousand TWD | -50.0% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | 98.823% |
| Level Biotechnology Inc. | 9.88 Million TWD | 92.777% |
| Sagittarius Life Science Corp | 6.25 Million TWD | 88.583% |
| NeoCore Technology Co., Ltd. | 33.65 Million TWD | 97.878% |
| TaiMed Biologics Inc. | 521.7 Million TWD | 99.863% |
| GlycoNex Incorporation | - TWD | -Infinity% |
| VBI | - TWD | -Infinity% |
| GeneReach Biotechnology Corp. | 97.74 Million TWD | 99.27% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | 99.178% |
| Visgeneer Inc. | 114.17 Million TWD | 99.375% |
| Mycenax Biotech Inc. | 569.78 Million TWD | 99.875% |
| Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 99.507% |
| G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | 44.822% |
| Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 99.719% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -51.271% |
| Enimmune corporation | 1.75 Million TWD | 59.409% |
| TaiRx, Inc. | 8.96 Million TWD | 92.039% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 436.54 Million TWD | 99.836% |
| BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | 98.612% |
| Sunny Pharmtech Inc. | 376.29 Million TWD | 99.81% |
| Lin BioScience, Inc. | 29.02 Million TWD | 97.54% |
| BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | 92.437% |
| Feng Chi Biotech Corp. | 8.14 Million TWD | 91.238% |
| Bio Preventive Medicine Corp. | 106.2 Million TWD | 99.328% |
| Lukas Biomedical Inc. | 69.9 Million TWD | 98.979% |
| RBC Bioscience Corporation | 412.59 Million TWD | 99.827% |
| BiOptic Inc. | 85.79 Million TWD | 99.168% |
| BRIM Biotechnology, Inc. | 108 Thousand TWD | -561.111% |
| Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
| Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | 93.438% |
| Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 99.815% |
| Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
| SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
| Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 99.679% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| NaviFUS Corp. | 25.83 Million TWD | 97.237% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 99.805% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | 96.758% |
| Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | 98.723% |
| Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | 91.204% |
| AP Biosciences Inc | 70.42 Million TWD | 98.986% |
| Medigen Biotechnology Corp. | 449.09 Million TWD | 99.841% |
| 3D Global Biotech Inc. | 4.08 Million TWD | 82.509% |
| Pharmosa Biopharm Inc. | 118.41 Million TWD | 99.397% |
| Intech Biopharm Corporation | 970.4 Million TWD | 99.926% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.821% |
| Eusol Biotech Co.,Ltd. | 1.6 Million TWD | 55.542% |
| TWi Biotechnology, Inc. | 5.6 Million TWD | 87.257% |
| Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -41.948% |
| TCI GENE Inc. | - TWD | -Infinity% |
| MegaPro Biomedical Co., Ltd | 5.62 Million TWD | 87.313% |
| Senhwa Biosciences, Inc. | 3.28 Million TWD | 78.278% |
| Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 99.715% |
| NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | 78.132% |
| PharmaEngine, Inc. | 7.14 Million TWD | 90.004% |
| Savior Lifetec Corporation | 257.03 Million TWD | 99.722% |
| TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | 98.784% |
| OBI Pharma, Inc. | 439.88 Million TWD | 99.838% |
| Meribank Biotech Co., Ltd | 14.81 Million TWD | 95.179% |
| Acepodia, Inc. | 233.45 Million TWD | 99.694% |
| Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | 93.987% |